# Helicobacter

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/helicobacter/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1083-4389 |
| ISSNs | 1083-4389,1523-5378 |
| OpenAlex ID | https://openalex.org/S45434965 |
| Publisher | Wiley |

## Journal papers

- [Epidemiology of<i>Helicobacter pylori</i>Infection](https://scholariq.org/papers/epidemiology-of-i-helicobacter-pylori-i-infection/)
- [Fifth Chinese National Consensus Report on the management of<i>Helicobacter pylori</i>infection](https://scholariq.org/papers/fifth-chinese-national-consensus-report-on-the-management-of-i-helicobacter/)
- [Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of <i>Helicobacter pylori</i>](https://scholariq.org/papers/systematic-review-with-meta-analysis-vonoprazan-a-potent-acid-blocker-is/)
- [<i>Toll‐Like Receptor 4 +</i>3725 G/C Polymorphism, <i>Helicobacter pylori</i> Seropositivity, and the Risk of Gastric Atrophy and Gastric Cancer in Japanese](https://scholariq.org/papers/i-toll-like-receptor-4-i-3725-g-c-polymorphism-i-helicobacter-pylori-i/)
- [The Efficacy of Second‐Line Anti‐<i>Helicobacter pylori</i> Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study](https://scholariq.org/papers/the-efficacy-of-second-line-anti-i-helicobacter-pylori-i-therapy-using-an/)
- [Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area](https://scholariq.org/papers/clinical-evaluation-of-a-ten-day-regimen-with-scp-e-scp-someprazole-scp-m-scp/)
- [Sensitivity of <i>Helicobacter pylori</i> detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity](https://scholariq.org/papers/sensitivity-of-i-helicobacter-pylori-i-detection-by-giemsa-staining-is-poor-in/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.